Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation Operating Income for the year ending December 31, 2023: USD -78.83 K

Savior Lifetec Corporation Operating Income is USD -78.83 K for the year ending December 31, 2023, a -104.65% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Savior Lifetec Corporation Operating Income for the year ending December 31, 2022 was USD 1.70 M, a 90.58% change year over year.
  • Savior Lifetec Corporation Operating Income for the year ending December 31, 2021 was USD 890.13 K, a -91.28% change year over year.
  • Savior Lifetec Corporation Operating Income for the year ending December 31, 2020 was USD 10.21 M, a 793.15% change year over year.
  • Savior Lifetec Corporation Operating Income for the year ending December 31, 2019 was USD 1.14 M, a 109.77% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

CEO Mr. Chih-Fang Chen
IPO Date Dec. 21, 2012
Location Taiwan
Headquarters 29, Ke-Jhong Road
Employees 384
Sector Health Care
Industries
Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Similar companies

4147.TWO

TaiMed Biologics Inc.

USD 2.64

-2.78%

4162.TWO

PharmaEngine, Inc.

USD 2.91

-0.09%

4157.TWO

TaiGen Biopharmaceuticals Holdings Limited

USD 0.32

0.12%

4192.TWO

SynCore Biotechnology Co.,Ltd

USD 1.02

-0.84%

StockViz Staff

January 15, 2025

Any question? Send us an email